About
ABCODIA LIMITED is a clinical stage company engaged in the development of novel tests for the early detection of cancer. We specialise in the development of software medical devices that can accurately interpret change in blood based biomarkers in a way that leads to the detection of cancer in the early stages when symptoms are not yet apparent. Our current focus is ovarian cancer, and our lead product is the ROCA® Test
Technologies
Outlook
Keywords
ovarian cancer
biomarkers
medical device software
services
surveillance technology
healthcare services
medical diagnostics
personalized risk profiling
risk-reducing surgery alternatives
women's health monitoring
roca algorithm
cost-effective screening
genetic risk management
ca-125 blood test
serial biomarker testing
clinical consultations
serial blood testing
personalized risk score
ca-125 serial measurements
risk management
early detection
nice endorsed ovarian cancer test
cost-saving surveillance
medical testing & diagnostics
risk stratification tools
ovarian cancer early detection
patient support services
roca care surveillance program
genetic counseling
women's health
Company Information
-
Employees 1
-
Founded 2010
-
Annual Revenue $4420000
-
Total Funding $11456183
Location
1 Park Row, New York, New York, United States, 10038
